(Q38050311)

27 August 2017

title

Pruritus: still a challenge (English)

1 reference

27 August 2017

Paulo Rowilson Cunha

1

1 reference

27 August 2017

Oswaldo Delfini Filho

series ordinal

2

1 reference

27 August 2017

publication date

1 September 2012

1 reference

Anais Brasileiros de Dermatologia

27 August 2017

published in

1 reference

27 August 2017

volume

87

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

735-741

1 reference

A role for polymodal C-fiber afferents in nonhistaminergic itch

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Separate peripheral pathways for pruritus in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Understanding pruritus in systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Chronic itch and chronic pain: Analogous mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Pruritus in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Comparative pharmacology of H1 antihistamines: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Vanilloid receptor-1 (VR1) is widely expressed on various epithelial and mesenchymal cell types of human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

The pruritus of cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

What causes itch in atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

IL-31: a new link between T cells and pruritus in atopic skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Neurotropic and psychotropic drugs in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

21 January 2018

Mirtazapine for pruritus

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Opioid peptides and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Butorphanol for treatment of intractable pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Itch associated with skin disease: advances in pathophysiology and emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Phototherapy for cutaneous T-cell lymphoma: online survey and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

The use of alternative or complementary medicine for children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0365-05962012000500011

10.1590/S0365-05962012000500011

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference